Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 31

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT03025789Phase 3Completed
Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage
Sleeping SicknessTrypanosomiasis, AfricanTrypanosomiasis; Gambian
PrincipalinvestigatorStart date: 2016-11-10

Research Network

Collaboration Network

4 collaborators·6 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

National HAT Control Programme, Kinshasa, The Democratic Republic of the Congo

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mamadou Camara, PhD

National HAT Control Programme, Conakry, Guinea

Moderately Similar
1 trials

Shared therapeutic areas:

Sleeping SicknessTrypanosomiasis, AfricanTrypanosomiasis; Gambian

Worked with same sponsors:

Drugs for Neglected DiseasesSanofi
Collaborated on 1 trial
Similarity Score34%

Médard Ilunga Wa Kyhi, MD

National HAT Control Programme, Kinshasa, The Democratic Republic of the Congo

Moderately Similar
1 trials

Shared therapeutic areas:

Sleeping SicknessTrypanosomiasis, AfricanTrypanosomiasis; Gambian

Worked with same sponsors:

Drugs for Neglected DiseasesSanofi
Collaborated on 1 trial
Similarity Score34%

Victor Kande Betu Kumeso, MD

Ministry of Health, Kinshasa, The Democratic Republic of the Congo

Moderately Similar
1 trials

Shared therapeutic areas:

Sleeping SicknessTrypanosomiasis, AfricanTrypanosomiasis; Gambian

Worked with same sponsors:

Drugs for Neglected DiseasesSanofi
Collaborated on 1 trial
Similarity Score34%

Enock Matovu, Prof

Makerere University

Related
1 trials

Shared therapeutic areas:

Sleeping SicknessTrypanosomiasis, African

Worked with same sponsors:

Drugs for Neglected Diseases
Similarity Score20%

Raquel Inocencio da Luz, PhD

Institute of Tropical Medicine

Related
1 trials

Shared therapeutic areas:

Sleeping SicknessTrypanosomiasis, African

Worked with same sponsors:

Drugs for Neglected Diseases
Similarity Score20%

Victor Kande Betu Ku Mesu, Dr

Ministry of Public Health, Hygiene and Prevention, Kinshasa

Related
1 trials

Shared therapeutic areas:

Sleeping SicknessTrypanosomiasis, African

Worked with same sponsors:

Drugs for Neglected Diseases
Similarity Score20%

Victor Kande Betu Kumeso, Dr.

Ministry of Public Health, Hygiene and Prevention, Kinshasa

Related
1 trials

Shared therapeutic areas:

Sleeping SicknessTrypanosomiasis, African

Worked with same sponsors:

Drugs for Neglected Diseases
Similarity Score20%

Victor Kande Betu Kumeso, Dr

Ministère de la Santé, The Democratic Republic of the Congo

Related
1 trials

Shared therapeutic areas:

Sleeping SicknessTrypanosomiasis, African

Worked with same sponsors:

Drugs for Neglected Diseases
Similarity Score20%

Veerle Lejon, PhD, HDR

Institut de Rechercher pour le Développement

Related
1 trials

Shared therapeutic areas:

Trypanosomiasis, AfricanSleeping Sickness
Similarity Score20%

Veerle Lejon, PhD

Institut de Recherche pour le Developpement

Related
2 trials

Shared therapeutic areas:

Trypanosomiasis, African
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT03025789Phase 3PrincipalInvestigator

Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage

Sleeping SicknessTrypanosomiasis, AfricanTrypanosomiasis; Gambian
Completed

All 1 trials loaded